Related Articles
2024 Cancer Survivorship Walkathon
Dawood Findakly’s Fundraising Page.
Virtual Mentoring Program
ASCO’s Virtual Mentoring Program pairs members with a mentor outside of their institution to address unmet career development needs of practicing oncologists, populations underrepresented in
Combined Hematology/Oncology and Hospice & Palliative Medicine
This program targets trainees wanting to further their palliative care skills to be able to deliver high-quality cancer care with palliative/supportive care integrated across the…
Precision treatment in advanced hepatocellular carcinoma
The past decade has witnessed significant advances in the systemic treatment of advanced hepatocellular carcinoma (HCC). Nevertheless, the newly devel…
Precision treatment in advanced hepatocellular carcinoma
The past decade has witnessed significant advances in the systemic treatment of advanced hepatocellular carcinoma (HCC). Nevertheless, the newly devel…
Bispecific antibodies for the treatment of B-cell lymphoma: promises, unknowns, and opportunities
Falchi and colleagues review the development of and clinical experience with bispecific antibodies, a class of T-cell redirecting drugs with excellent activity
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC | NEJM
Original Article from The New England Journal of Medicine — Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
FDA Approves Momelotinib for Myelofibrosis With Anemia
The FDA has approved momelotinib (Ojjaara) for the treatment of adult patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis or secondary myelofibrosis, and anemia.
Targeted Therapy in Follicular Lymphoma: Towards a Chemotherapy-Free Approach
Background: The treatment of follicular lymphoma (FL) has previously centered on chemoimmunotherapy, which can be disadvantageous due to patient intolerance, cumulative toxicities, and disease refractoriness.…